Your browser doesn't support javascript.
loading
CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia.
Williams, Kelly L; Topp, Simon; Yang, Shu; Smith, Bradley; Fifita, Jennifer A; Warraich, Sadaf T; Zhang, Katharine Y; Farrawell, Natalie; Vance, Caroline; Hu, Xun; Chesi, Alessandra; Leblond, Claire S; Lee, Albert; Rayner, Stephanie L; Sundaramoorthy, Vinod; Dobson-Stone, Carol; Molloy, Mark P; van Blitterswijk, Marka; Dickson, Dennis W; Petersen, Ronald C; Graff-Radford, Neill R; Boeve, Bradley F; Murray, Melissa E; Pottier, Cyril; Don, Emily; Winnick, Claire; McCann, Emily P; Hogan, Alison; Daoud, Hussein; Levert, Annie; Dion, Patrick A; Mitsui, Jun; Ishiura, Hiroyuki; Takahashi, Yuji; Goto, Jun; Kost, Jason; Gellera, Cinzia; Gkazi, Athina Soragia; Miller, Jack; Stockton, Joanne; Brooks, William S; Boundy, Karyn; Polak, Meraida; Muñoz-Blanco, José Luis; Esteban-Pérez, Jesús; Rábano, Alberto; Hardiman, Orla; Morrison, Karen E; Ticozzi, Nicola; Silani, Vincenzo.
Afiliação
  • Williams KL; Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales 2109, Australia.
  • Topp S; Northcott Neuroscience Laboratory, ANZAC Research Institute, Sydney, New South Wales 2139, Australia.
  • Yang S; Sydney Medical School, University of Sydney, Sydney, New South Wales 2006, Australia.
  • Smith B; Medical Research Council Centre for Neurodegeneration Research, Department of Clinical Neuroscience, Institute of Psychiatry, King's College London, London SE5 8AF, UK.
  • Fifita JA; Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales 2109, Australia.
  • Warraich ST; Northcott Neuroscience Laboratory, ANZAC Research Institute, Sydney, New South Wales 2139, Australia.
  • Zhang KY; Medical Research Council Centre for Neurodegeneration Research, Department of Clinical Neuroscience, Institute of Psychiatry, King's College London, London SE5 8AF, UK.
  • Farrawell N; Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales 2109, Australia.
  • Vance C; Northcott Neuroscience Laboratory, ANZAC Research Institute, Sydney, New South Wales 2139, Australia.
  • Hu X; Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales 2109, Australia.
  • Chesi A; Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales 2109, Australia.
  • Leblond CS; Illawarra Health and Medical Research Institute, School of Biological Sciences, University of Wollongong, Wollongong, New South Wales 2522, Australia.
  • Lee A; Medical Research Council Centre for Neurodegeneration Research, Department of Clinical Neuroscience, Institute of Psychiatry, King's College London, London SE5 8AF, UK.
  • Rayner SL; Medical Research Council Centre for Neurodegeneration Research, Department of Clinical Neuroscience, Institute of Psychiatry, King's College London, London SE5 8AF, UK.
  • Sundaramoorthy V; Department of Genetics, Stanford University School of Medicine, Stanford, California 94305, USA.
  • Dobson-Stone C; Montreal Neurological Institute and Hospital, Department of Neurology and Neurosurgery, McGill University, Montreal, Québec, Canada H3A 2B4.
  • Molloy MP; Pathology and Cellular Biology Department, Montreal University, Montreal, QC H3T 1J4 Québec, Canada.
  • van Blitterswijk M; Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales 2109, Australia.
  • Dickson DW; Australian Proteome Analysis Facility, Macquarie University, Sydney, New South Wales 2109, Australia.
  • Petersen RC; Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales 2109, Australia.
  • Graff-Radford NR; Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales 2109, Australia.
  • Boeve BF; Department of Biochemistry, La Trobe University, Melbourne, Victoria 3086, Australia.
  • Murray ME; Neuroscience Research Australia, Randwick, Sydney, New South Wales 2031, Australia.
  • Pottier C; School of Medical Sciences, University of New South Wales, Kensington, Sydney, New South Wales 2052, Australia.
  • Don E; Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales 2109, Australia.
  • Winnick C; Australian Proteome Analysis Facility, Macquarie University, Sydney, New South Wales 2109, Australia.
  • McCann EP; Department of Neuroscience, Mayo Clinic Florida, Jacksonville, Florida 32224, USA.
  • Hogan A; Department of Neuroscience, Mayo Clinic Florida, Jacksonville, Florida 32224, USA.
  • Daoud H; Department of Neurology, Mayo Clinic Rochester, Rochester, Minneapolis 55905, USA.
  • Levert A; Department of Neurology, Mayo Clinic Florida, Jacksonville, Florida, 32224, USA.
  • Dion PA; Department of Neurology, Mayo Clinic Rochester, Rochester, Minneapolis 55905, USA.
  • Mitsui J; Department of Neuroscience, Mayo Clinic Florida, Jacksonville, Florida 32224, USA.
  • Ishiura H; Department of Neuroscience, Mayo Clinic Florida, Jacksonville, Florida 32224, USA.
  • Takahashi Y; Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales 2109, Australia.
  • Goto J; Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales 2109, Australia.
  • Kost J; Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales 2109, Australia.
  • Gellera C; Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales 2109, Australia.
  • Gkazi AS; Montreal Neurological Institute and Hospital, Department of Neurology and Neurosurgery, McGill University, Montreal, Québec, Canada H3A 2B4.
  • Miller J; Pathology and Cellular Biology Department, Montreal University, Montreal, QC H3T 1J4 Québec, Canada.
  • Stockton J; Montreal Neurological Institute and Hospital, Department of Neurology and Neurosurgery, McGill University, Montreal, Québec, Canada H3A 2B4.
  • Brooks WS; Pathology and Cellular Biology Department, Montreal University, Montreal, QC H3T 1J4 Québec, Canada.
  • Boundy K; Montreal Neurological Institute and Hospital, Department of Neurology and Neurosurgery, McGill University, Montreal, Québec, Canada H3A 2B4.
  • Polak M; Pathology and Cellular Biology Department, Montreal University, Montreal, QC H3T 1J4 Québec, Canada.
  • Muñoz-Blanco JL; Medical Genome Center, The University of Tokyo Hospital, The University of Tokyo, Tokyo 113-8655, Japan.
  • Esteban-Pérez J; Medical Genome Center, The University of Tokyo Hospital, The University of Tokyo, Tokyo 113-8655, Japan.
  • Rábano A; Medical Genome Center, The University of Tokyo Hospital, The University of Tokyo, Tokyo 113-8655, Japan.
  • Hardiman O; Medical Genome Center, The University of Tokyo Hospital, The University of Tokyo, Tokyo 113-8655, Japan.
  • Morrison KE; Worcester Polytechnic Institute, Worcester, Massachusetts 01609, USA.
  • Ticozzi N; Department of Neurology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, USA.
  • Silani V; Unit of Genetics of Neurodegenerative and Metabolic Diseases, Fondazione IRCCS Istituto Neurologico 'Carlo Besta', 20133 Milan, Italy.
Nat Commun ; 7: 11253, 2016 Apr 15.
Article em En | MEDLINE | ID: mdl-27080313
ABSTRACT
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are overlapping, fatal neurodegenerative disorders in which the molecular and pathogenic basis remains poorly understood. Ubiquitinated protein aggregates, of which TDP-43 is a major component, are a characteristic pathological feature of most ALS and FTD patients. Here we use genome-wide linkage analysis in a large ALS/FTD kindred to identify a novel disease locus on chromosome 16p13.3. Whole-exome sequencing identified a CCNF missense mutation at this locus. Interrogation of international cohorts identified additional novel CCNF variants in familial and sporadic ALS and FTD. Enrichment of rare protein-altering CCNF variants was evident in a large sporadic ALS replication cohort. CCNF encodes cyclin F, a component of an E3 ubiquitin-protein ligase complex (SCF(Cyclin F)). Expression of mutant CCNF in neuronal cells caused abnormal ubiquitination and accumulation of ubiquitinated proteins, including TDP-43 and a SCF(Cyclin F) substrate. This implicates common mechanisms, linked to protein homeostasis, underlying neuronal degeneration.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ciclinas / Predisposição Genética para Doença / Mutação de Sentido Incorreto / Demência Frontotemporal / Esclerose Lateral Amiotrófica Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Nat Commun Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ciclinas / Predisposição Genética para Doença / Mutação de Sentido Incorreto / Demência Frontotemporal / Esclerose Lateral Amiotrófica Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Nat Commun Ano de publicação: 2016 Tipo de documento: Article